INGELVAC® PRRS KV

Ingelvac® PRRS KV (killed vaccine) is indicated for the control of Porcine and Respiratory Syndrome in breeding sows and gilts.

Gilts should be vaccinated with Ingelvac PRRS KV during acclimatization and before entering the pig herd. After their initial course, animals are boosted once during each pregnancy. Vaccinated animals show improved reproductive performance as shown by fewer early farrowings and stillbirths. In addition, vaccinated animals produce fewer infected piglets and pass on improved colostral immunity.

More information

Uses

For reduction of the reproductive disorders in sows and gilts caused by Porcine Reproductive and Respiratory Syndrome virus (European strain), in a contaminated environment. Vaccination reduces the number of early farrowings and the number of stillbirths.

Contraindications and Warnings

Vaccination may induce a transient oedema (up to 3 cm) generally lasting less than one week, and a small local reaction (granulomas) without any adverse effects on the health and performance of the animal. Larger reactions (up to 7 cm diameter) have been occasionally observed after frequent repeated vaccinations. Vaccination may rarely cause hypersensitivity reactions. In such cases appropriate symptomatic treatment should be carried out. Vaccinate only healthy animals. Use normal procedures for handling animals. No adverse effects on serological response have been observed when the vaccine is administered simultaneously (but via a separate injection site) with inactivated vaccines against parvovirus, influenza and Aujeszky’s disease. It is recommended that no other vaccine should be administered at the same time as the product. No undesirable effects were observed after administering the vaccine to pregnant or lactating animals.

Withdrawal Period

Zero Days

Pharmaceutical Precautions

Store at 2°C to 8°C (in a refrigerator), protected from light.
Do not mix with other medicinal products.
Use immediately after opening.

Legal Category

POM

Marketing Authorisation Number

Vm 00015/4064

Marketing Authorisation Holder

Boehringer Ingelheim Limited, Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS UK

Sunday 5th July

Search Site